Status:
UNKNOWN
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Leukemia, Lymphoblastic
Eligibility:
All Genders
1-18 years
Brief Summary
This is a multicenter retrospective study (Reims and Nancy), with data collection over 12 years from 01/01/2010 to 12/31/2022 Patients included are children diagnosed with acute lymphoblastic leukemia...
Eligibility Criteria
Inclusion
- Children between 1 and 18 years old diagnosed with Medium risk/ High Risk B acute lymphoblastic leukemia or Standard/ High Risk T acute lymphoblastic leukemia between 2010 and 2021 in Nancy and Reims.
Exclusion
- Patients less than 1 year old
- leukémia with philadelphia chromosome
- standard risk B acute lymphoblastic leukemia
- bone marrow transplant during treatment
- death during the year following diagnosis
- refusal of the patient (parents) to participate in the study
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06110182
Start Date
October 1 2023
End Date
May 1 2025
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Vandœuvre-lès-Nancy, France, 54500